Invega Sustenna reduces psychiatric hospitalisation rates: Ortho-McNeil
Data for the analysis were from two Phases of the clinical trial, a double-blind, randomised, relapse-prevention maintenance phase that compared Invega Sustenna to placebo and a one-year open-label
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.